Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > Kenneth Galbraith 5th highest paid CEO in CANADA

<< Previous

Bullboard Posts

Next >>

Comment by stockbuphoonon Jun 08, 2020 2:55pm

86 Views

Post# 31125410

RE:RE:Kenneth Galbraith 5th highest paid CEO in CANADA

This is absolutely shocking for someone who produced nothing, leads an enterprise with market cap of only $250-300M and continues to kick the cab down the road on any clinical trials with 4050 after 5 years having passed on IPF and MetSyn. What is Thomvest thinking? They are paying them like they market cap of 10x like back in 2016.